Vonk, Alieke G <br/><br/>
Host defence against disseminated Candida albicans infection and implications for antifungal immunotherapy.  [electronic resource] 

 -  Expert opinion on biological therapy  Sep 2006 
 - 891-903 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7682 
<br/><br/><label>Standard No.: </label>10.1517/14712598.6.9.891  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--economics<br/>Animals<br/>Antifungal Agents--therapeutic use<br/>Candida albicans--immunology<br/>Candidiasis--drug therapy<br/>Complement System Proteins--immunology<br/>Dendritic Cells--immunology<br/>Drug Therapy, Combination<br/>Fluconazole--therapeutic use<br/>Fungal Vaccines--administration & dosage<br/>Granulocyte Colony-Stimulating Factor--therapeutic use<br/>Humans<br/>Immunity, Cellular--drug effects<br/>Immunity, Innate--drug effects<br/>Interferon-gamma--therapeutic use<br/>Killer Cells, Natural--immunology<br/>Phagocytes--immunology<br/>Randomized Controlled Trials as Topic--economics<br/>Receptors, Pattern Recognition--immunology<br/>Recombinant Proteins<br/>Th1 Cells--immunology<br/>Th2 Cells--immunology